No products
Product successfully added to your shopping cart
There are 0 items in your cart. There is 1 item in your cart.
View larger
AASC-OX
Optimized Xtract - Anti-Addiction (Smoking Cessation) Research
AASC-OX Scientifically Engineered Mu-Opioid Receptor Antagonist Optimized Extract
Concurrent Potent Inhibitory Modulation of AChNRs, VMAT, and DAT.
Indications for anti-addiction (smoking cessation, stimulant cessation), anxiolytic, antidepressant, and vigilance/focus/ADHD research.
In Stock
Warning: Last items in stock!
More info
Introducing our TLR SEP-OX Scientifically Engineered Proprietary Herbal Extracts
Introductory Special 30% Off!
Optimized Xtract - Anti-Addiction (Smoking Cessation) Research
AASC-OX Scientifically Engineered Mu-Opioid Receptor Antagonist Optimized Extract
Concurrent Potent Inhibitory Modulation of AChNRs, VMATs, and DAT.
Source: Proprietary
Developed toward the goal of an Optimized Xtract to foster smoking cessation and as an adjunct aid within anti-addiction spectrum paradigms. In murine model assays AASC-OX inhibited nicotine craving behaviors in a superior fashion to varenicline with doses administered at 6-12x that of varenicline. ED50 results respective to varenicline reflected a dosage of 8.1x that of varenicline. Within rats superior effects on nicotine craving behavior abolition and weight gain attenuation were demonstrated as compared to naltrexone with a doage potency of 8-fold.
Demonstrates moderate locomotor stimulation and antidepressant/anxiolytic effects in animal models. Assays for enhanced cognitive function are slated with repect for pursuit of research toward goal indications of ADHD, et. al.
Mostly soluble in aqueous solution at 3-10mg/ml
USAGE: For Research Use Only! Not For Use in Humans.
FREE "EMBEDDED" OFFER:
FREE 200mg TLR SEP-OX AASC-OX upon request with any order of both J147 98% and NSI-189 Phosphate 99%.
USAGE: For Research Use Only! Not For Use in Humans.
(upon request - limit to only one free item offer and $0.01 item offer per order)